Clinical trial
Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With…
NCT00107809 · Cephalon, Industry · Completed
Key facts
| NCT number | NCT00107809 |
|---|---|
| Title | Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome |
| Official title | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of PROVIGIL ® (Modafinil) Treatment (100, 200, and 400 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome |
| Lead sponsor | Cephalon, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sleep Apnea, Obstructive |
| Intervention type | Drug |
| Interventions | Modafinil |
| Enrollment | 140 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Apr 11, 2005 |
| Last update posted | May 9, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: